Aerobic oxidation of indolomorphinan without the 4,5-epoxy bridge and subsequent rearrangement of the oxidation product to spiroindolinonyl- C-normorphinan derivative
Aerobic oxidation of indolomorphinan 1 without a 4,5-epoxy bridge proceeded in the presence of platinum catalyst to give indoleninomorphinan 2 or quinolono- C-normorphinan 5. The 4-hydroxy group would play an important role in deciding the course of the reaction. Treatment of 2a with 1,8-diazabicycl...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry 2009-08, Vol.17 (16), p.5983-5988 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Aerobic oxidation of indolomorphinan
1 without a 4,5-epoxy bridge proceeded in the presence of platinum catalyst to give indoleninomorphinan
2 or quinolono-
C-normorphinan
5. The 4-hydroxy group would play an important role in deciding the course of the reaction. Treatment of
2a with 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) gave spiroindolinonyl-
C-normorphinan
3a whose structure resembles that of δ opioid receptor agonist spiroindanyloxymorphone (SIOM). Boron trichloride was effective for the reverse reaction from
3a to
2a without side reaction. This practical interconversion method between hydroxyindolenine and spiroindolinone would be useful for the design and construction of drug-like compound libraries. Although the compound
3b was expected to show the selectivity for δ opioid receptor because of the structural resemblance to SIOM, it was rather selective for μ opioid receptor (μ:
K
i
=
0.75
nM; δ:
K
i
=
2.90
nM; κ:
K
i
=
13.4
nM). The result suggests that the slight difference of the spatial location of the benzene rings in these compounds may definitively affect the binding affinity for δ opioid receptor.
Indolomorphinan without 4,5-epoxy bridge
1a was easily oxidized to give indoleninomorphinan
2a. Practical interconversion between indoleninomorphinan
2a and spiroindolinonyl-
C-normorphinan
3a became possible. |
---|---|
ISSN: | 0968-0896 1464-3391 |
DOI: | 10.1016/j.bmc.2009.06.067 |